Gateway 2011: Corden Pharma - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: Corden Pharma


Corden Pharma
Otto-Hahn-Strasse
68723 Plankstadt, Germany
Phone: +49 6202 99-2299
Fax: +49 6202 99-2000
E-mail: sales@cordenpharma.com
Website: www.cordenpharma.com

General Company Company Description:

Corden Pharma is a specialized contract manufacturer utilizing sophisticated technologies developed through years of proven experience that are ideal for the production of oral and sterile highly potent or antibiotic pharmaceutical products and their active ingredients.

We offer customised service packages which span the entire pharmaceutical product continuum from development and manufacturing of Active Pharmaceuticals Ingredients, formulation development, assistance with approval procedures, and commercial production of Drug Products, all the way to complete pharmaceutical logistics.

Our plants, located across Europe and in the US, are audited by all relevant approval authorities, making Corden Pharma a premier partner for pharmaceutical companies worldwide.

Visit Corden Pharma at CPhI booth 31B04 and/or AAPS booth 1524 to discover the services, technologies and products which distinguish Corden Pharma as a Full-Service Development and Contract Manufacturer:

  • Custom API Manufacturing
  • Generic API Manufacturing
  • Drug Product Development and Manufacturing
  • Generic Dossier Development
  • Formulation Capabilities
  • Packaging
  • Clinical Supply Services
  • Specialized Technologies, including High Potent APIs and Peptides
  • Readily Available Excipients, Building Blocks and Generic Bulk APIs

Contact:
sales@cordenpharma.com to arrange meetings for CPhI
contactUS@cordenpharma.com to arrange meetings for AAPS

PDF/Online Documents

Corden Pharma Switzerland Custom Manufacturing Brochure

Corden Pharma Switzerland Lipids Brochure

Corden Pharma Switzerland Lipids Price List

Corden Pharma Switzerland Pseudoproline Dipeptides Brochure

Corden Pharma Switzerland Pseudoproline Dipeptides Price List

Corden Pharma Switzerland Oligonucleotide-Based Therapeutic Delivery

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search

Click here